They also bought Valtech:
https://www.timesofisrael.com/edwards-lifesciences-to-buy-israels-valtech-cardio-for-up-to-690/
So with us, sheep trial done with flying colours, soon human trials.
the market is sleeping, our TAVR is the real deal, same way Wayne surprised with the patch deal, hopefully soon another surprise. IMO
DYOR
Why Admedus’ shift to aortic valve replacement is good news for patients under 65, page-13
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
-0.300(1.64%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.29 | $18.30 | $17.65 | $181.7K | 10.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $17.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.00 | 499 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |